F. R. Sharipov

4 та иш

Tashkent Pediatric Medical Institute

1. Effectiveness of cytoflavin in patients with high risk development of cerebrovascular diseases.

   Y. N. Madzhidova, Bakhodir Yusupaliev, F. R. Sharipov +2

   МақолаNeurological Disorders and TreatmentsClinical Medicine (Russian Journal)20202 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.001153

2. Neuroprotective therapy in chronic cerebrovascular diseases

   O. V. Kim, Yo. N. Madzhidova, F. R. Sharipov

   МақолаNeurological Disorders and TreatmentsRussian neurological Journal20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.002398

3. Dynamics of neurocognitive indicators against the background of neuroprotective therapy of vertebrobasilar insufficiency with cerebral venous discirculation symptoms

   O. V. Kim, Ya. N. Madjidova, F. R. Sharipov

   МақолаNeurological Disorders and TreatmentsAntibiot Khimioter = Antibiotics and Chemotherapy20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.001553

4. Efficacy and Safety Of D-, L-Hopanthenic Acid (Pantogam Active) In the Correction of Cognitive and Emotional Disorders in Patients with Arterial Hypertension

   Y.N. Madjidova, G.O. Toshulatova, F. R. Sharipov

   МақолаNeurological Disorders and TreatmentsInternational journal of modern medicine20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.010182